This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cynosure Receives Australian Regulatory Approval To Market PicoSure™, The First Picosecond Laser To Remove Tattoos And Benign Pigmented Lesions

WESTFORD, Mass., Nov. 6, 2013 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that Australia's Therapeutic Goods Administration has granted marketing clearance for the PicoSure™ Picosecond Laser, the world's first picosecond laser for the removal of tattoos and benign pigmented lesions. PicoSure was introduced in the United States earlier this year after receiving clearance from the U.S. Food and Drug Administration. The product also is being marketed in the European Union and Canada.  

"PicoSure continues to be enthusiastically received by physicians and consumers in North America and Europe, and we are excited about the opportunity to market the product to our customers and their patients in Australia, which is a new direct sales territory for the Company," said Cynosure President and CEO Michael Davin.

The Company also received approval from the China Food and Drug Administration to market Smartlipo MPX™ LaserBodySculpting™ Workstation, the industry's leading laser-assisted lipolysis system designed to disrupt fat cells and tighten tissue through tissue coagulation. In addition, the PinPointe™ FootLaser™, which Cynosure distributes through an exclusive worldwide agreement with NuvoLase Inc., has been cleared by the Korea Food & Drug Administration for the treatment of Onychomycosis, commonly known as nail fungus.

"Further expanding our international product reach is an important part of our long-term growth strategy," Davin said. "International markets generate nearly half of our total laser revenue. Our goal is to continue to enhance our presence in high-growth regions by capitalizing on our outstanding brand reputation, broad distribution capabilities and strong customer relationships. With our innovative laser treatments rapidly gaining in popularity and accessibility around the world, Cynosure is playing an integral role in driving the growth of the global aesthetic market."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs